L
Live / Applied — Third extension granted (statement of use) (as of 31 Mar 2026)
What this means for you
Not registered yet, but its 30 Oct 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98246359
- Mark type
- Word mark
- Filed
- 30 Oct 2023
- Published for opposition
- 27 Aug 2024
- Attorney of record
- Bruce W. Longbottom
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations in tablet form for medicinal purposes, namely, for treatment of cancer, cardiovascular diseases, diabetes, kidney diseases and disorders, liver diseases and disorders, and obesity
- Class 044 — Medical, beauty and agricultural services: Medical information services; arranging and providing medical information services relating to pharmaceuticals, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
Owner
- Eli Lilly and Company, Indianapolis, IN, US
- Eli Lilly and Company, Indianapolis, IN, US
Prosecution history
- 02 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Mar 2026 — SOU EXTENSION 3 GRANTED
- 31 Mar 2026 — SOU EXTENSION 3 FILED
- 31 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 18 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Sept 2025 — SOU EXTENSION 2 GRANTED
- 17 Sept 2025 — SOU EXTENSION 2 FILED
- 17 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Mar 2025 — SOU EXTENSION 1 GRANTED
- 14 Mar 2025 — SOU EXTENSION 1 FILED
- 14 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Aug 2024 — PUBLISHED FOR OPPOSITION